中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib

文献类型:期刊论文

作者Wang, Deping; Feng, Yubing; Zhuang, Xiaoxi; Zhang, Fengxiang; Liu, Jianqi; Leng, Fang; Lang, Xingfen; Bai, Yang; She, Miaoqin; Tu, Zhengchao
刊名JOURNAL OF MEDICINAL CHEMISTRY
出版日期2013
卷号56期号:3
ISSN号0022-2623
学科主题Pharmacology & Pharmacy
语种英语
源URL[http://ir.foo.ac.cn/handle/2SETSVCV/274]  
专题中国科学院广州生物医药与健康研究院
推荐引用方式
GB/T 7714
Wang, Deping,Feng, Yubing,Zhuang, Xiaoxi,et al. Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib[J]. JOURNAL OF MEDICINAL CHEMISTRY,2013,56(3).
APA Wang, Deping.,Feng, Yubing.,Zhuang, Xiaoxi.,Zhang, Fengxiang.,Liu, Jianqi.,...&Ren, Xiaomei.(2013).Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib.JOURNAL OF MEDICINAL CHEMISTRY,56(3).
MLA Wang, Deping,et al."Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib".JOURNAL OF MEDICINAL CHEMISTRY 56.3(2013).

入库方式: OAI收割

来源:广州生物医药与健康研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。